ReWalk Robotics Ltd (RWLK)
(Delayed Data from NSDQ)
$3.76 USD
+0.05 (1.35%)
Updated May 3, 2019 04:00 PM ET
After-Market: $3.74 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Lifeward Ltd. [RWLK]
Reports for Purchase
Showing records 1 - 20 ( 29 total )
Company: Lifeward Ltd.
Industry: Medical - Instruments
Entering Growth and Execution Phase in 2024 and Beyond; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Lifeward Ltd.
Industry: Medical - Instruments
Reimbursement Decision Expected in 4Q23, Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Lifeward Ltd.
Industry: Medical - Instruments
AlterG Acquisition Brings New Commercial Opportunities; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Lifeward Ltd.
Industry: Medical - Instruments
CMS Proposes to Include Exoskeletons Under Benefit Category of Braces; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Lifeward Ltd.
Industry: Medical - Instruments
Germany and CMS to Provide Long-Term Growth; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Lifeward Ltd.
Industry: Medical - Instruments
ReWalk Receives Additional Navigation Power; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Lifeward Ltd.
Industry: Medical - Instruments
Looking Forward to a Year of Execution; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Lifeward Ltd.
Industry: Medical - Instruments
Successful German Legal Proceeding Clears Commercial Path; Increasing PT to $3; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Lifeward Ltd.
Industry: Medical - Instruments
CMS Opens Reimbursement Pathway Through MACs; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Lifeward Ltd.
Industry: Medical - Instruments
CMS Decision Could be a Game Changer; Adjusting PT to $2.50; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Lifeward Ltd.
Industry: Medical - Instruments
CMS Decision Could Drive Long-Term US Growth; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Lifeward Ltd.
Industry: Medical - Instruments
Pivotal Year for Reimbursement Coverage; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Lifeward Ltd.
Industry: Medical - Instruments
Well Positioned for Sustainable Growth; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Lifeward Ltd.
Industry: Medical - Instruments
Company: Lifeward Ltd.
Industry: Medical - Instruments
German Market to Provide ReWalk Personal Growth in 2H21; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Lifeward Ltd.
Industry: Medical - Instruments
Growth Could Continue Through 2021E and Beyond; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Lifeward Ltd.
Industry: Medical - Instruments
Reinvigorating Growth With A Strong Balance Sheet; Higher $3.50 PT; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Lifeward Ltd.
Industry: Medical - Instruments
German Contracts Expanding; Rehabilitation Segment Targets Clinic Networks; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Lifeward Ltd.
Industry: Medical - Instruments
This report covers the Multiple Sclerosis Drug Market
Provider: Standpoint Research
Analyst: Research Department
Company: Lifeward Ltd.
Industry: Medical - Instruments
German Contracts Could Generate Growth; Lower $2.50 PT on Dilution; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S